Clinical Trials · NCT04353193

Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.

UnknownPhase 4Octreotide (Unclear)
Phase
Phase 4
Recruitment status
Unknown
Sponsor
Juan A. Arnaiz
Enrollment
36
Start date
Jun 2020
Locations
1 site, Spain
Primary endpoint
Change in HVPG
View Octreotide compound reference